| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |